The 14th International Conference on

Miniaturized Systems for Chemistry and Life Sciences

Home | General Info | Program Committee | Previous Conferences| Different periodic tables | Conference Officials |

Abstract Guidelines | CBMS Directors | Awards | Authors | Grouping methods | Periodic trends and patterns |Contact

 


Einsteinium





 

Einsteinium

Einsteinium is a synthetic element with the symbol Es and atomic number 99. As a member of the actinide series, it is the seventh transuranic element.

Einsteinium was discovered as a component of the debris of the first hydrogen bomb explosion in 1952, and named after Albert Einstein. Its most common isotope einsteinium-253 (half-life 20.47 days) is produced artificially from decay of californium-253 in a few dedicated high-power nuclear reactors with a total yield on the order of one milligram per year. The reactor synthesis is followed by a complex process of separating einsteinium-253 from other actinides and products of their decay. Other isotopes are synthesized in various laboratories, but in much smaller amounts, by bombarding heavy actinide elements with light ions. Owing to the small amounts of produced einsteinium and the short half-life of its most easily produced isotope, there are currently almost no practical applications for it outside basic scientific research. In particular, einsteinium was used to synthesize, for the first time, 17 atoms of the new element mendelevium in 1955.

Like all actinides, einsteinium is rather reactive. Its trivalent oxidation state is most stable in solids and aqueous solution where it induces a pale pink color.[40] The existence of divalent einsteinium is firmly established, especially in the solid phase; such +2 state is not observed in many other actinides, including protactinium, uranium, neptunium, plutonium, curium and berkelium. Einsteinium(II) compounds can be obtained, for example, by reducing einsteinium(III) with samarium(II) chloride. The oxidation state +4 was postulated from vapor studies and is yet uncertain.

Because of the short half-life of all isotopes of einsteinium, any primordial einsteinium that is, einsteinium that could possibly have been present on the Earth during its formation has long since decayed. Synthesis of einsteinium from naturally-occurring actinides uranium and thorium in the Earth's crust requires multiple neutron capture, which is an extremely unlikely event. Therefore, all terrestrial einsteinium is produced in scientific laboratories, high-power nuclear reactors, or in nuclear weapons tests, and is present only within a few years from the time of the synthesis. The transuranic elements from americium to fermium, including einsteinium, occurred naturally in the natural nuclear fission reactor at Oklo, but no longer do so. Einsteinium was observed in Przybylski's Star in 2008.

The atmospheric results were supplemented by the underground test data accumulated in the 1960s at the Nevada Test Site, as it was hoped that powerful explosions conducted in confined space might result in improved yields and heavier isotopes. Apart from traditional uranium charges, combinations of uranium with americium and thorium have been tried, as well as a mixed plutonium-neptunium charge, but they were less successful in terms of yield and was attributed to stronger losses of heavy isotopes due to enhanced fission rates in heavy-element charges. Product isolation was problematic as the explosions were spreading debris through melting and vaporizing the surrounding rocks at depths of 300600 meters. Drilling to such depths to extract the products was both slow and inefficient in terms of collected volumes.

Separation of trivalent actinides from lanthanide fission products can be done by a cation-exchange resin column using a 90% water/10% ethanol solution saturated with hydrochloric acid (HCl) as eluant. It is usually followed by anion-exchange chromatography using 6 molar HCl as eluant. A cation-exchange resin column (Dowex-50 exchange column) treated with ammonium salts is then used to separate fractions containing elements 99, 100 and 101. These elements can be then identified simply based on their elution position/time, using -hydroxyisobutyrate solution (-HIB), for example, as eluant.

The high radioactivity of einsteinium has a potential use in radiation therapy, and organometallic complexes have been synthesized in order to deliver einsteinium atoms to an appropriate organ in the body. Experiments have been performed on injecting einsteinium citrate (as well as fermium compounds) to dogs. Einsteinium(III) was also incorporated into beta-diketone chelate complexes, since analogous complexes with lanthanides previously showed strongest UV-excited luminescence among metallorganic compounds. When preparing einsteinium complexes, the Es3+ ions were 1000 times diluted with Gd3+ ions. This allowed reducing the radiation damage so that the compounds did not disintegrate during the period of 20 minutes required for the measurements. The resulting luminescence from Es3+ was much too weak to be detected. This was explained by the unfavorable relative energies of the individual constituents of the compound that hindered efficient energy transfer from the chelate matrix to Es3+ ions. Similar conclusion was drawn for other actinides americium, berkelium and fermium.

Most of the available einsteinium toxicity data originate from research on animals. Upon ingestion by rats, only about 0.01% einsteinium ends in the blood stream. From there, about 65% goes to the bones, where it remains for about 50 years, 25% to the lungs (biological half-life about 20 years, although this is rendered irrelevant by the short half-lives of einsteinium isotopes), 0.035% to the testicles or 0.01% to the ovaries where einsteinium stays indefinitely. About 10% of the ingested amount is excreted. The distribution of einsteinium over the bone surfaces is uniform and is similar to that of plutonium.







 

 Copyright 2009, All Rights Reserved, MicroTAS2010

manuals on this site